OVID
Ovid Therapeutics Inc.
$1.29
+$0.08(+6.61%)
45
Overall
--
Value
45
Tech
--
Quality
Market Cap
$81.06M
Volume
1.34M
52W Range
$0.24 - $1.47
Target Price
$2.88
Order:
Income Statement
| Metric | Trend | Chart | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||
| Total Revenue | -- | -- | -- | $12.6M | $208.4M | $1.5M | $392.0K | $566.0K | ||
| Total Revenue | -- | -- | -- | $12.6M | $208.4M | $1.5M | $392.0K | $566.0K | ||
| GROSS PROFIT | ||||||||||
| Gross Profit | -- | -- | -- | $12.6M | $208.4M | $1.5M | $392.0K | $566.0K | ||
| OPERATING EXPENSES | ||||||||||
| Operating Expenses | $-65.0M | $-52.9M | $60.5M | $94.0M | $84.2M | $57.1M | $59.7M | $62.5M | ||
| Research & Development | $50.0M | $33.8M | $42.2M | $63.4M | $46.9M | $24.6M | $28.6M | $36.8M | ||
| Research Expense | $50.0M | $33.8M | $42.2M | $63.4M | $46.9M | $24.6M | $28.6M | $36.8M | ||
| Selling, General & Administrative | $15.0M | $19.1M | $19.3M | $30.6M | $37.2M | $32.4M | $31.1M | $25.7M | ||
| General & Administrative Expenses | $15.0M | $19.1M | $19.3M | $30.6M | $37.2M | $32.4M | $31.1M | $25.7M | ||
| Salaries & Wages | $-6.4M | $-7.1M | $-5.2M | -- | -- | -- | $7.3M | $6.3M | ||
| Depreciation & Amortization | $-26.9K | $-35.0K | $-39.0K | $60.0K | $76.9K | $319.2K | $400.0K | $400.0K | ||
| Depreciation & Amortization | $-26.9K | $-35.0K | $-39.0K | $60.0K | $76.9K | $319.2K | $400.0K | $400.0K | ||
| Amortization | $-53.4K | $-106.0K | $-216.0K | $247.0K | $160.2K | $193.3K | $100.0K | $200.0K | ||
| Other Operating Expenses | $-65.0M | $-52.9M | $-948.2K | $-395.4K | $45.7K | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||
| Operating income | $-65.0M | $-52.9M | $-60.5M | $-81.4M | $124.2M | $-55.5M | $-59.3M | $-61.9M | ||
| EBITDA | $-64.7M | $-51.8M | $-60.2M | $-81.1M | $124.4M | $-54.2M | $-50.7M | $-24.7M | ||
| NON-OPERATING ITEMS | ||||||||||
| Intinc | $201.5K | $952.1K | $948.2K | -- | -- | -- | $4.9M | $3.9M | ||
| Net Non-Operating Interest Income/Expense | $201.5K | $952.1K | $948.2K | -- | -- | -- | $4.9M | $3.9M | ||
| Gain on Sale of Securities | -- | -- | -- | -- | -- | -- | $2.0M | $3.3M | ||
| Other Income/Expense | -- | -- | -- | -- | $45.7K | $1.4M | $-6.9M | $-35.5M | ||
| Other Special Charges | -- | -- | -- | -- | $-45.7K | $1.4M | $6.9M | $35.5M | ||
| SPECIAL ITEMS | ||||||||||
| Restructring And Mn A Income | -- | -- | -- | -- | -- | -- | $1.7M | $3.5M | ||
| Special Income Charges | -- | -- | -- | -- | -- | -- | $-1.7M | $-3.5M | ||
| PRE-TAX INCOME | ||||||||||
| EBIT | $-64.8M | $-52.0M | $-60.5M | $-81.4M | $124.2M | $-55.5M | $-52.3M | $-26.4M | ||
| Pre-Tax Income | $-64.8M | $-52.0M | $-60.5M | $-81.0M | $124.2M | $-54.2M | $-52.3M | $-26.4M | ||
| INCOME TAX | ||||||||||
| Tax Provision | -- | -- | -- | -- | $1.3M | -- | -- | -- | ||
| NET INCOME | ||||||||||
| Net Income | $-64.8M | $-52.0M | $-60.5M | $-81.0M | $122.8M | $-54.2M | $-52.3M | $-26.4M | ||
| Net Income (Continuing Operations) | $-64.8M | $-52.0M | $-60.5M | $-81.0M | $122.8M | $-54.2M | $-52.3M | $-26.4M | ||
| Net Income (Discontinued Operations) | $-64.8M | $-52.0M | $-60.5M | $-81.0M | $122.8M | $-54.2M | $-52.3M | $-26.4M | ||
| Net Income (Common Stockholders) | $-64.8M | $-52.0M | $-60.5M | $-81.0M | $119.8M | $-54.2M | $-52.3M | $-26.4M | ||
| Normalized Income | -- | -- | -- | -- | $98.1M | -- | -- | $-22.7M | ||
| TOTALS | ||||||||||
| Total Expenses | $-65.0M | $-52.9M | $60.5M | $94.0M | $84.2M | $57.1M | $59.7M | $62.5M | ||
| SHARE & EPS DATA | ||||||||||
| Average Shares Outstanding | $19.3M | $24.6M | $39.2M | $58.5M | $67.5M | $70.4M | $70.6M | -- | ||
| Average Shares Outstanding (Diluted) | $19.3M | $24.6M | $39.2M | -- | $68.1M | $70.4M | $70.6M | -- | ||
| Shares Outstanding | $24.6M | $38.6M | $54.7M | $65.8M | $70.4M | $70.5M | $71.1M | $71.1M | ||
| Basic EPS | -- | -- | -- | $-1.39 | $1.78 | $-0.77 | $-0.74 | $-0.37 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | $-1.39 | $1.78 | $-0.77 | $-0.74 | -- | ||
| Diluted EPS | $-3.35 | $-2.11 | $-1.54 | $-1.39 | $1.76 | $-0.77 | $-0.74 | $-0.37 | ||
| Diluted EPS (Continuing Operations) | -- | -- | $-1.54 | -- | $1.76 | $-0.77 | $-0.74 | -- | ||
| OTHER METRICS | ||||||||||
| Other Gand A | $15.0M | $19.1M | $19.3M | $30.6M | $37.2M | $32.4M | $31.1M | $25.7M | ||
| Rent And Landing Fees | $15.0M | $19.1M | -- | -- | -- | $-2.3M | $-2.3M | -- | ||
| Restruct | -- | -- | -- | -- | -- | -- | $1.7M | $3.5M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | OVID | $1.29 | +6.6% | 1.34M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |